NextCell is attending a conference for worldleading celltherapies
NextCell Pharma AB ("NextCell" or the"Company") is attending the International Society for Cell and Gene Therapy 2022 in San Francisco, May 4-7. The company is represented by Mathias Svahn, CEO who is a member of the Business Development and Finance Committee will participate in workshops, round table discussions and partnering meetings.Established in 1992, ISCT is the global society fostering cell and gene therapy translation to the clinic. The society is comprised of over 2,200 cell therapy experts across five geographic regions and from over 60 countries. ISCT members are part of a